Founded
1 Aug 1987
Website
VCID: 114095
Profile
Corporate information
Official name
Gilead Sciences Incorporated
Registration country
Investment activity status
Active investor
Company type
A biopharmaceutical company that discovers, develops and commercializes therapeutics.Funding
Funding rounds
(31 Dec 1988)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Biotechnology Venture Fund | India | Initial investment. Round participant. | |
|
Venrock Associates | The venture capital arm of the Rockefeller Family. | United States | Initial investment. Round participant. |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Menlo Ventures | Bay Area venture capital firm that invests early stage across consumer, enterprise, and healthcare technologies. | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Biotechnology Venture Fund |
+91 (44) 2432-9864 |
N/A |
|
|
Menlo Ventures Bay Area venture capital firm that invests early stage across consumer, enterprise, and healthcare technologies. |
+1 (650) 854-8540 |
N/A |
|
|
Venrock Associates The venture capital arm of the Rockefeller Family. |
+1 (617) 995-2000 |
N/A |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
|
Calistoga Pharmaceuticals Inc Biopharmaceutical company dedicated to developing targeted therapies to improve the health of patients with cancer or inflammatory diseases. |
United States | 1 Apr 2011 | Acquisition Active |
|
|
|
Arresto BioSciences Inc A biotechnology company, develops medicines to treat cancer and fibrotic diseases |
United States | 20 Dec 2010 | Acquisition USD 225,000,000 (USD 225,000,000) deal size. Active |
|
|
|
CGI Pharmaceuticals Inc A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. |
United States | 8 Jul 2010 | Acquisition USD 120,000,000 (USD 120,000,000) deal size. |
|
|
|
Corus Pharma Inc A specialty pharmaceutical development company developing and obtaining regulatory approvals of products for respiratory and infectious diseases. |
United States | 1 Aug 2006 | Acquisition USD 365,000,000 (USD 365,000,000) deal size. |
|
|
|
Triangle Pharmaceuticals Inc Anti-viral and oncology licensing company. |
United States | 4 Dec 2002 | Acquisition USD 464,000,000 (USD 464,000,000) deal size. |
|
|
|
Achillion Pharmaceuticals Inc Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. |
United States | N/A Initial investment. Round participant. Active |